دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Methylprednisolone as Adjunct to Endovascular Thrombectomy for Large-Vessel Occlusion Stroke
doi : 10.1001/jama.2024.0626
March 12, 2024, Vol 331, No. 10, Pages 813-894
ADHD Pharmacotherapy and Mortality in Individuals With ADHD
Lin Li, PhD1; Nanbo Zhu, MSc1; Le Zhang, PhD1; Ralf Kuja-Halkola, PhD1; Brian M. D’Onofrio, PhD1,2; Isabell Brikell, PhD1,3; Paul Lichtenstein, PhD1; Samuele Cortese, MD, PhD4,5,6,7; Henrik Larsson, PhD8; Zheng Chang, PhD1
doi : 10.1001/jama.2024.0851
Adolescent Δ8-THC and Marijuana Use in the US
Alyssa F. Harlow, PhD1,2,3; Richard A. Miech, PhD4; Adam M. Leventhal, PhD1,2,3
doi : 10.1001/jama.2024.0865
Prevalence of Immunosuppression Among US Adults
Melissa L. Martinson, PhD1; Jessica Lapham, PhD1
doi : 10.1001/jama.2023.28019
Medicare Eligibility and Reported Support for Proposals to Expand Medicare
Nolan M. Kavanagh, MPH1; Andrea L. Campbell, PhD2; Adrianna McIntyre, PhD, MPP, MPH3
doi : 10.1001/jama.2024.0379
Responding Effectively to Disruptive Patient Behaviors
Rachel Fabi, PhD1; L. Syd M Johnson, PhD1
doi : 10.1001/jama.2024.0216
State Approaches to Stopping Violence Against Health Care Workers
Rebekah J. Ninan, BA, MMSc1; I. Glenn Cohen, JD2; Eli Y. Adashi, MD, MS3
doi : 10.1001/jama.2024.1140
Adjunctive Steroids as Stroke Reperfusion Strategy
James E. Siegler, MD1; Shyam Prabhakaran, MD, MS1
doi : 10.1001/jama.2024.0526
Treating Attention-Deficit/Hyperactivity Disorder Matters
Frances R. Levin, MD1,2; Mariely Hernandez, PhD1,2; John J. Mariani, MD1,2
doi : 10.1001/jama.2024.1755
The Public Health Challenge of Δ8-THC and Derived Psychoactive Cannabis Products
Jennifer M. Whitehill, PhD1; Kelly E. Dunn, PhD, MBA2; Renee M. Johnson, PhD, MPH3
doi : 10.1001/jama.2024.0801
Advancing Equity at the JAMA Network—Self-Reported Demographics of Editors and Editorial Board Members
Kirsten Bibbins-Domingo, MD, PhD, MAS1; Annette Flanagin, RN, MA2; Caroline Sietmann, MLIS3; Robert O. Bonow, MD, MS4; Ann Marie Navar, MD, MHS, PhD5; Kanade Shinkai, MD, PhD6; Mya L. Roberson, PhD7; John Z. Ayanian, MD, MPP8; Ninez Ponce, PhD9; Sharon K. Inouye, MD, MPH10; Raegan W. Durant, MD, MPH11; Melissa A. Simon, MD, MPH12; Frederick P. Rivara, MD, MPH13; Monica Vela, MD14; S. Andrew Josephson, MD15; Ashley Rawls, MD, MS16; Mary L. (Nora) Disis, MD17; Narjust Florez, MD18; Neil M. Bressler, MD19; Adrienne W. Scott, MD20; Jay F. Piccirillo, MD21; Nosayaba Osazuwa-Peters, BDS, PhD, MPH, CHES22; Dimitri A. Christakis, MD, MPH23; Andrea F. Duncan, MD, MSClinRes24; Dost Öngür, MD, PhD25; Kara S. Bagot, MD26; Melina R. Kibbe, MD27; Leah Monique Backhus, MD, MPH28; Preeti N. Malani, MD, MSJ29
doi : 10.1001/jama.2024.1709
Allergic Rhinitis
Jonathan A. Bernstein, MD1; Joshua S. Bernstein, MD1; Richika Makol, MD2; Stephanie Ward, MD2
doi : 10.1001/jama.2024.0530
More Than Half of US Rural Hospitals No Longer Offer Birthing Services—Here’s Why
Samantha Anderer
doi : 10.1001/jama.2024.1278
FDA Adds Boxed Warning to CAR T-Cell Therapies, but Says Benefits Outweigh Risks of Secondary Cancers
Melissa Suran, PhD, MSJ
doi : 10.1001/jama.2024.1011
Tirzepatide Lowered Blood Pressure in People With Obesity
Emily Harris
doi : 10.1001/jama.2024.0726
Studies to Test How Well PREVENT Predicts Heart Disease in Diverse Groups
Emily Harris
doi : 10.1001/jama.2024.0727
New Antiviral on the Horizon for Mild to Moderate COVID-19
Emily Harris
doi : 10.1001/jama.2024.0729
High Lipoprotein(a) May Increase CVD Risk Even Without Inflammation
Emily Harris
doi : 10.1001/jama.2024.0730
New Prevention Guidance for Antibiotic-Resistant Meningococcal Cases
Emily Harris
doi : 10.1001/jama.2024.0731
Psychedelic Drugs Might Support Sexual Well-Being, Studies Find
Emily Harris
doi : 10.1001/jama.2024.0733
Virtual Group Exercise Program Improved Long COVID Symptoms
Emily Harris
doi : 10.1001/jama.2024.0734
Clinicians’ Misperceptions a Barrier to Lifesaving Diarrhea Treatment
Emily Harris
doi : 10.1001/jama.2024.0735
GLP-1 Receptor Agonists and Gastrointestinal Adverse Events
Karine Suissa, PhD1; Sara J. Cromer, MD2; Elisabetta Patorno, MD, DrPH1
doi : 10.1001/jama.2024.0046
GLP-1 Receptor Agonists and Gastrointestinal Adverse Events—Reply
Ramin Rezaeianzadeh, BSc1; Mohit Sodhi, MSc1; Mahyar Etminan, PharmD, MSc2
doi : 10.1001/jama.2024.0049
Vitamin C for Patients Hospitalized With COVID-19
Cathrine McKenzie, PhD1; Lorraine Moore, PGDip2; Mark Borthwick, MSc3
doi : 10.1001/jama.2024.0452
Vitamin C for Patients Hospitalized With COVID-19—Reply
Neill K. J. Adhikari, MDCM, MSc1; Francois Lamontagne, MD, MSc2
doi : 10.1001/jama.2024.0455
Sigh Breaths in Patients With Trauma Receiving Mechanical Ventilation
Richard K. Albert, MD1; Erika S. Helgeson, PhD2
doi : 10.1001/jama.2024.0117
